Form D · Other
SystImmune, Inc.
Redmond, WA · CIK 0002016790
Offering snapshot reported Oct 18, 2024 · SEC filing
- Reported sold
- $7.91M Offering amount: $7.91M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 18, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 18, 2024 | Initial | $7,911,989 | No comparison | 2 | SEC filing |
| Jun 4, 2024 | Initial | $7,176,168 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-527250
We offer eligible executive officers options under the Amended and Restated Executive Option Plan.
Stock options and underlying stock offered to executive officers.
No commissions are given.
Source: Form D, filed Oct 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jie D'elia | Executive |
| Suya Zhang | Director |
| Yi Zhu | Director, Executive |
| Hai Zhu | Director |
Issuer details
Industry: Other (See others in industry)
Address:
15318 Ne 95 Th St
Redmond, WA, 98052
Redmond, WA, 98052